| | Issue Date | Title | Author(s) |
| 21 | 1-Aug-2013 | Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: Influence of the position 4 substituent | Hamed, Mostafa M.; Abou El Ella, Dalal ; Keeton, Adam B.; Piazza, Gary A.; Engel, Matthias; Hartmann, Rolf W.; Abadi, Ashraf H. |
| 22 | Sep-2013 | 6-Aryl and heterocycle quinazoline derivatives as potent EGFR inhibitors with improved activity toward gefitinib-sensitive and -resistant tumor cell lines | Hamed, Mostafa M; Abou El Ella, Dalal ; Keeton, Adam B; Piazza, Gary A; Abadi, Ashraf H; Hartmann, Rolf W; Engel, Matthias |
| 23 | Oct-2013 | Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold | Al-Ansary, Ghada H; Ismail, Mohamed A H; Abou El Ella, Dalal ; Eid, Sameh; Abouzid, Khaled |
| 24 | Oct-2013 | Synthesis and Antifungal Activity of Some New Substituted5, 7- Diiodo-8-Hydroxy Quinoline Derivatives | Hoda H. Fahmy; Nagy M. Khalifa; Abou El Ella, Dalal ; Mohamed A. Ismail; Noha M. Mostafa; Abdelhamid A. Hamdy |
| 25 | Jun-2014 | Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers | Hussein, Mohammed M; Serya, Rabah ; Abdel Naby, Rana M; Al-Abd, Ahmed M; Saleh, Dalia O; El-Eraky, Wafaa I; Khaled A M Abouzid ; Abou El Ella, Dalal |
| 26 | Oct-2014 | Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold | Shahin, Mai I; Abou El Ella, Dalal ; Ismail, Nasser S M; Abouzid, Khaled |
| 27 | 2015 | Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors | Serya, Rabah ; Abbas, Abeer Hussin; Ismail, Nasser Saad Mohamed; Esmat, Ahmed; Abou El Ella, Dalal |
| 28 | 2015 | Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents | Elrazaz, Eman ; Abou El Ella, Dalal ; Khaled A M Abouzid ; Rabah A.T. Serya; Nasser S.M. Ismail |
| 29 | 2015 | Molecular modeling design, synthesis, and anti-hyprglycemic evaluation of certain 5-(aryl-alkoxy-benzylidine)-imidazolidine-2,4-dione derivatives as potential PPAR gamma agonists | Ismail, MAH; Abouzid, Khaled ; Abdou, NS; Lahham, A; Abou El Ella, Dalal |
| 30 | 1-Feb-2015 | Synthesis, 3D pharmacophore, QSAR and docking studies of novel quinazoline derivatives with nitric oxide release moiety as preferential COX-2 inhibitors | Farag, Doaa Boshra; Farag, Nahla A.; Ahmed Esmat ; Abuelezz, Sally A.; Abdel-Salam Ibrahim, Eman; Abou El Ella, Dalal |
| 31 | 15-Jul-2015 | Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking | Eldehna, Wagdy M; Fares, Mohamed; Ibrahim, Hany S; Aly, Mohamed H; Zada, Suher; Ali, Mamdouh M; Abou-Seri, Sahar M; Abdel-Aziz, Hatem A; Abou El Ella, Dalal |
| 12 | 18-Sep-2015 | Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity | Ibrahim, Diaa A; Abou El Ella, Dalal ; El-Motwally, Amira M; Aly, Rasha M |
| 13 | 2016 | Design, synthesis and biological evaluation of indazole–pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activities | Elsayed, Nevine M. Y.; Abou El Ella, Dalal ; Serya, Rabah A. T.; Tolba, Mai F.; Shalaby, Raed; Khaled A M Abouzid |
| 14 | 2016 | Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents | Ismail, Nasser S.M.; Ali, Eslam M.H.; Ibrahim, Diaa A.; Serya, Rabah A.T.; Abou El Ella, Dalal |
| 15 | 1-Jan-2016 | 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation | Abou-Seri, Sahar M; Eldehna, Wagdy M; Ali, Mamdouh M; Abou El Ella, Dalal |
| 16 | 3-Mar-2016 | Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII | Eldehna, Wagdy M; Fares, Mohamed; Ceruso, Mariangela; Ghabbour, Hazem A; Abou-Seri, Sahar M; Abdel-Aziz, Hatem A; Abou El Ella, Dalal ; Supuran, Claudiu T |
| 17 | May-2016 | Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity | El Newahie, Aliya M S; Ismail, Nasser S M; Abou El Ella, Dalal ; Abouzid, Khaled |
| 18 | May-2016 | Quinoline-based small molecules as effective protein kinases inhibitors (Review) | Rasha M. Aly; Rabah A. T. Serya; Amira M. El-Motwally; Ghada H. Al-Ansary; Abou El Ella, Dalal |
| 19 | 4-May-2016 | Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives | Eldehna, Wagdy M; Abou-Seri, Sahar M; El Kerdawy, Ahmed M; Ayyad, Rezk R; Hamdy, Abdallah M; Ghabbour, Hazem A; Ali, Mamdouh M; Abou El Ella, Dalal |
| 20 | 29-Nov-2016 | Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers | Ghorab, Mostafa M; Alsaid, Mansour S; Al-Ansary, Ghada H; Abdel-Latif, Ghada A; Abou El Ella, Dalal |